Aziyo Biologics Inc. (AZYO)
NASDAQ: AZYO
· Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM
Aziyo Biologics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 13.12M | 13.14M | 13.24M | 28.64M | 35.76M | 42.14M | 48.4M | 50.74M | 49.19M | 47.38M | 46.48M | 46M | 47.39M | 48.99M | 49.28M | 45.7M |
Cost of Revenue | 15.61M | 15.9M | 15.61M | 19.27M | 22.81M | 26.99M | 31.05M | 29.47M | 29.96M | 29.77M | 30.22M | 29.03M | 28.37M | 27.34M | 25.78M | 24.03M |
Gross Profit | 8.81M | 8.55M | 8.94M | 9.36M | 12.95M | 15.15M | 17.35M | 21.27M | 19.22M | 17.62M | 16.26M | 16.97M | 19.02M | 21.65M | 23.5M | 21.68M |
Operating Income | -42.72M | -41.35M | -40.8M | -35.2M | -29.47M | -26.51M | -25.46M | -24.56M | -26.97M | -29.18M | -29.84M | -26.25M | -23.03M | -19.23M | -14.95M | -14.12M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -39.28M | -58.05M | -62.63M | -46.19M | -55.45M | -32.52M | -33.91M | -32.69M | -32.86M | -36.47M | -34.88M | -27.86M | -24.78M | -21.07M | -19.49M | -22.3M |
Net Income | -38.08M | -56.65M | -62.47M | -47.48M | -56.52M | -33.78M | -33.95M | -32.72M | -32.9M | -36.52M | -34.93M | -27.91M | -24.83M | -21.12M | -19.54M | -22.33M |
Selling & General & Admin | 30.87M | 31.42M | 30.08M | 28.71M | 30.24M | 30.68M | 34.52M | 37.36M | 37.26M | 36.57M | 35.55M | 33.41M | 32.79M | 33.72M | 32.72M | 30.53M |
Research & Development | 3.39M | 2.94M | 2.59M | 3.51M | 4.53M | 5.62M | 7.03M | 8.47M | 8.94M | 10.23M | 10.55M | 9.82M | 9.27M | 7.16M | 5.74M | 5.26M |
Other Expenses | 2.3M | 1.5M | 2.31M | 2.31M | 810K | 810K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 36.57M | 35.86M | 34.98M | 34.53M | 35.58M | 37.1M | 41.55M | 45.83M | 46.2M | 46.8M | 46.1M | 43.23M | 42.05M | 40.89M | 38.45M | 35.79M |
Interest Expense | 3M | 3.74M | 4.11M | 5.37M | 5.78M | 6.08M | 5.93M | 5.61M | 5.28M | 5.01M | 5.04M | 5.18M | 5.32M | 5.42M | 5.56M | 5.62M |
Selling & Marketing Expenses | 10.57M | 10.12M | 9.89M | 12.74M | 15.11M | 16.83M | 18.95M | 20.73M | 20.2M | 19.68M | 19.55M | 18.94M | 18.82M | 18.66M | 18.05M | 17.31M |
Cost & Expenses | 52.18M | 51.76M | 50.59M | 53.8M | 58.39M | 64.09M | 72.59M | 75.3M | 76.16M | 76.57M | 76.32M | 72.26M | 70.42M | 68.23M | 64.23M | 59.82M |
Income Tax Expense | -5K | -24K | -20K | 21K | 25K | 34K | 34K | 34K | 34K | 48K | 48K | 54K | 55K | 51K | 47K | 34K |
Shares Outstanding (Basic) | 41.78M | 38.62M | 29.07M | 32.52M | 24.77M | 17.02M | 16.22M | 16.15M | 14.47M | 13.66M | 13.62M | 13.57M | 11.09M | 10.24M | 10.23M | 10.23M |
Shares Outstanding (Diluted) | 46.31M | 29.07M | 29.07M | 35.52M | 26.27M | 17.02M | 16.22M | 16.15M | 14.47M | 13.66M | 13.62M | 13.57M | 11.09M | 10.24M | 10.23M | 10.23M |
EPS (Basic) | -0.45 | -1.36 | -1.83 | -2.33 | -2.85 | -2.09 | -2.25 | -2.29 | -2.4 | -2.84 | -2.92 | -2.46 | -2.36 | -2.06 | -1.91 | -2.19 |
EPS (Diluted) | -0.52 | -1.33 | -1.76 | -2.26 | -2.78 | -2.09 | -2.25 | -2.29 | -2.4 | -2.84 | -2.92 | -2.46 | -2.36 | -2.06 | -1.91 | -2.19 |
EBITDA | -55.26M | -53.9M | -53.35M | -35.2M | -29.47M | -25.36M | -25.11M | -24.21M | -25.7M | -29.06M | -27.98M | -24.39M | -22.1M | -18.3M | -14.95M | -13.14M |
EBIT | 11.93M | 11.93M | 4.87M | -7.06M | -11.93M | -17.55M | -17.78M | -17.78M | -19.83M | -14.22M | -13.9M | -14.91M | -7.99M | -7.99M | -6.27M | -9.02M |
Depreciation & Amortization | -1.86M | -1.86M | -1.9M | 914.41K | 1.86M | 6.82M | 6.06M | 6.04M | 6.02M | 1.99M | 3.73M | 3.73M | 3.73M | 3.74M | 3.78M | 3.82M |